Genetically Engineered Antibody Molecules: New Tools for Cancer Therapy
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 6 (2) , 185-192
- https://doi.org/10.3109/07357908809077046
Abstract
(1988). Genetically Engineered Antibody Molecules: New Tools for Cancer Therapy. Cancer Investigation: Vol. 6, No. 2, pp. 185-192. doi: 10.3109/07357908809077046Keywords
This publication has 34 references indexed in Scilit:
- Tolerance to rat monoclonal antibodies. Implications for serotherapy.The Journal of Experimental Medicine, 1986
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986
- Protection of Mice Against Tetanus Toxin by Combination of Two Human Monoclonal Antibodies Recognizing Distinct Epitopes on the Toxin MoleculeHybridoma, 1986
- Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibodyJournal of Immunological Methods, 1985
- A hapten-specific chimaeric IgE antibody with human physiological effector functionNature, 1985
- Production of functional chimaeric mouse/human antibodyNature, 1984
- Recombinant antibodies possessing novel effector functionsNature, 1984
- Biological and Clinical Implications of Lymphocyte Hybridomas: Tumor Therapy with Monoclonal AntibodiesAnnual Review of Medicine, 1983
- Plasmid-Determined Resistance to Antimicrobial AgentsAnnual Review of Microbiology, 1978
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975